IBDEI2TY ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,47502,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47502,1,3,0)
 ;;=3^Peripheral T-Cell Lymphoma,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,47502,1,4,0)
 ;;=4^C84.48
 ;;^UTILITY(U,$J,358.3,47502,2)
 ;;=^5001649
 ;;^UTILITY(U,$J,358.3,47503,0)
 ;;=C84.49^^209^2346^433
 ;;^UTILITY(U,$J,358.3,47503,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47503,1,3,0)
 ;;=3^Peripheral T-Cell Lymphoma,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,47503,1,4,0)
 ;;=4^C84.49
 ;;^UTILITY(U,$J,358.3,47503,2)
 ;;=^5001650
 ;;^UTILITY(U,$J,358.3,47504,0)
 ;;=C84.60^^209^2346^47
 ;;^UTILITY(U,$J,358.3,47504,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47504,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Positive,Unspec Site
 ;;^UTILITY(U,$J,358.3,47504,1,4,0)
 ;;=4^C84.60
 ;;^UTILITY(U,$J,358.3,47504,2)
 ;;=^5001651
 ;;^UTILITY(U,$J,358.3,47505,0)
 ;;=C84.61^^209^2346^48
 ;;^UTILITY(U,$J,358.3,47505,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47505,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Positive,Head/Face/Neck Nodes
 ;;^UTILITY(U,$J,358.3,47505,1,4,0)
 ;;=4^C84.61
 ;;^UTILITY(U,$J,358.3,47505,2)
 ;;=^5001652
 ;;^UTILITY(U,$J,358.3,47506,0)
 ;;=C84.62^^209^2346^49
 ;;^UTILITY(U,$J,358.3,47506,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47506,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Positive,Intrathoracic Nodes
 ;;^UTILITY(U,$J,358.3,47506,1,4,0)
 ;;=4^C84.62
 ;;^UTILITY(U,$J,358.3,47506,2)
 ;;=^5001653
 ;;^UTILITY(U,$J,358.3,47507,0)
 ;;=C84.63^^209^2346^50
 ;;^UTILITY(U,$J,358.3,47507,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47507,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Positive,Intra-Abdominal Nodes
 ;;^UTILITY(U,$J,358.3,47507,1,4,0)
 ;;=4^C84.63
 ;;^UTILITY(U,$J,358.3,47507,2)
 ;;=^5001654
 ;;^UTILITY(U,$J,358.3,47508,0)
 ;;=C84.64^^209^2346^51
 ;;^UTILITY(U,$J,358.3,47508,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47508,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Positive,Axilla/Upper Limb Nodes
 ;;^UTILITY(U,$J,358.3,47508,1,4,0)
 ;;=4^C84.64
 ;;^UTILITY(U,$J,358.3,47508,2)
 ;;=^5001655
 ;;^UTILITY(U,$J,358.3,47509,0)
 ;;=C84.65^^209^2346^52
 ;;^UTILITY(U,$J,358.3,47509,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47509,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Positive,Ing Region/Lower Limb Nodes
 ;;^UTILITY(U,$J,358.3,47509,1,4,0)
 ;;=4^C84.65
 ;;^UTILITY(U,$J,358.3,47509,2)
 ;;=^5001656
 ;;^UTILITY(U,$J,358.3,47510,0)
 ;;=C84.66^^209^2346^53
 ;;^UTILITY(U,$J,358.3,47510,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47510,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Positive,Intrapelvic Nodes
 ;;^UTILITY(U,$J,358.3,47510,1,4,0)
 ;;=4^C84.66
 ;;^UTILITY(U,$J,358.3,47510,2)
 ;;=^5001657
 ;;^UTILITY(U,$J,358.3,47511,0)
 ;;=C84.67^^209^2346^54
 ;;^UTILITY(U,$J,358.3,47511,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47511,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Positive,Spleen
 ;;^UTILITY(U,$J,358.3,47511,1,4,0)
 ;;=4^C84.67
 ;;^UTILITY(U,$J,358.3,47511,2)
 ;;=^5001658
 ;;^UTILITY(U,$J,358.3,47512,0)
 ;;=C84.68^^209^2346^55
 ;;^UTILITY(U,$J,358.3,47512,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47512,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Positive,Mult Site Nodes
 ;;^UTILITY(U,$J,358.3,47512,1,4,0)
 ;;=4^C84.68
 ;;^UTILITY(U,$J,358.3,47512,2)
 ;;=^5001659
 ;;^UTILITY(U,$J,358.3,47513,0)
 ;;=C84.69^^209^2346^56
 ;;^UTILITY(U,$J,358.3,47513,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,47513,1,3,0)
 ;;=3^Anaplastic Large Cell Lymphoma,ALK-Positive,Extranodal/Solid Organ Sites
 ;;^UTILITY(U,$J,358.3,47513,1,4,0)
 ;;=4^C84.69
